SBIR-STTR Award

Control of Schistosomiasis by Rotifer Emissions
Award last edited on: 6/2/2009

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$350,000
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Margaret A Stirewalt

Company Information

Biomedical Research Inc

12111 Parklawn Drive
Rockville, MD 20852
   (301) 881-3300
   N/A
   N/A
Location: Single
Congr. District: 08
County: Montgomery

Phase I

Contract Number: 1R43AI021587-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1984
Phase I Amount
$50,000
Schistosomiasis, caused by parasitic flatworms living in the mesenteric/vesical veins, is the second most important infectious disease of man. Producing chronic illness, it spreads with increasing demands for water and intensified irrigation in developing countries. It is a major contributor to the high level of morbidity and mortality in endemic areas. Mollusciciding, sanitary engineering and chemotherapy have not been able to keep the disease in check. Additional control measures are needed. One such approach involves biological interference with disease transmission in the field. To some extent interference with transmission occurs naturally: by predation of cercariae, miracidia and snails by certain, fish, prawns, annelids, turbellaria and carnivorous plants. A new approach to reducing transmission depends on immobilization of cercariae, the larval which infects man by penetrating intact skin. In the laboratory a watersoluble factor emitted by a symbiotic rotifer species colonizing vector snails does this by paralyzing the cercariae and thus reducing their capacity to emerge from snails and to infect man. Phase I objectives are to: fractionate this anticercarial rotifer factor in water from cloned cultures of rotifer; isolate and purify the active fraction(s); and characterize and define it chemically and structurally.

Thesaurus Terms:
communicable disease control agents, anthelmintics, parasitic diseases, helminth infections, schistosomiasis, rotifers, tropical medicine and parasitology study section chemical structure--biological activity growth microorganisms, microbial culture, physical separation, chromatography

Phase II

Contract Number: 2R44AI021587-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1986
(last award dollars: 1987)
Phase II Amount
$300,000

Schistosomiasis is one of the most pervasive infectious diseases in the world, affecting nearly 10 percent of the earth's population. Its transmission from the snail intermediate host to man is a point at which many control strategies have been aimed.A new approach to transmission control is related to the discovery of a stable biological product that causes almost instantaneous paralysis of Schistosoma mansoni cercariae. Its novelty derives from its source: It is produced by a single species of rotifers, a group of ubiquitous free-living aquatic organisms.As this product is liberated in apparently minute quantities into a complex medium, its structural identification is possible only after it is sufficiently purified from contaminating soluble components. Major Phase II efforts will be to isolate the compound using high-performance liquid chromatography, after which structural determination will be made using a battery of analytical methods, including mass and IR spectrometry. Its activity will also be assessed against a variety of other pathogens, and attempts will be made to define its mode of action against a variety of other pathogens, and attempts will be made to define its mode of action against cercariae. The results of these and other projects should determine its potential as an effective control agent in endemic regions of the world.National Institute of Allergy and Infectious Diseases (NIAID)